PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2011
CASE
AUTH/2387/2/11 ALK-Abelló ⭐ Case of the Week

ALK-AbellΓ³: Jext formulary materialsβ€”misleading β€œ33% longer shelf-life” claim (AUTH/2387/2/11)

Formulary pack/template for Jext claimed β€œ33% longer shelf-life”. Panel said wording implied patients would receive a full 24 months’ shelf life, which…

2011
CASE
AUTH/2408/6/11 Abbott Laboratories

Abbott Laboratories: EULAR 2011 conference bag sponsorship ruled an unacceptable promotional aid (AUTH/2408/6/11)

Abbott’s logo appeared on EULAR 2011 congress bags distributed in London after the 2011 Code transition period. The Panel ruled the bags…

2011
CASE
AUTH/2389/2/11 Alcon Laboratories

AUTH/2389/2/11: Allergan v Alcon – Travatan β€œthornless rose” visual and lab-data tolerability claims

A Travatan β€œBAK-free” ad used a thornless rose and animal/in vitro data implying better tolerability vs BAK formulation. PMCPA found the ad…

2008
CASE
Roche Products

Anonymous v Roche: alleged conflict of interest (rep married to hepatitis C nurse specialist) – No breach

Anonymous NHS complaint alleged conflict of interest, speaker fees, bonuses and a Caribbean reward trip linked to Pegasys sales. Panel had concerns…

2011
CASE
AUTH/2412/6/11 Eli Lilly

AUTH/2412/6/11: Anonymous v Lilly β€” Byetta samples supplied to a hospital (No breach)

Anonymous hospital staff member alleged Lilly supplied large quantities of Byetta samples to drive prescribing. Panel found sampling met Code requirements and…

2011
CASE
AUTH/2443/10/11 Genus Pharmaceuticals ⭐ Case of the Week

AUTH/2443/10/11: Anonymous v Genus Pharmaceuticals β€” conduct of Apo-go nurse advisor (No breach)

Anonymous pharmacist alleged an Apo-go nurse advisor changed Parkinson’s medicines without authority and failed to inform PDNSs. Panel found the nurse support…

2018
CASE
AUTH/3091/9/18 UCB

UCB: EU Clinical Trials Register results not posted on time (Director complaint) β€” AUTH/3091/9/18

BMJ analysis suggested 5 UCB trials lacked EUCTR results. Panel found two UK-site trials (RA0056/RA0057) not posted within required timeframe, breaching Clause…

2018
CASE
AUTH/3082/9/18 Bristol-Myers Squibb

AUTH/3082/9/18: Director v Bristol-Myers Squibb (Clinical trial disclosure) β€” Outwith scope / No breach

PMCPA case AUTH/3082/9/18 (Director v Bristol-Myers Squibb) on clinical trial disclosure was ruled outwith the scope of the ABPI Code (2016). No…

2012
CASE
AUTH/2523/7/12 Teva

AUTH/2523/7/12: Anonymous v Teva β€” country club venue for VAT meeting (no breach)

Teva sponsored a VAT management workshop held at a golf and country club. The Panel said sponsors must ensure venues are appropriate,…

2012
CASE
AUTH/2503/5/12 Genus

Genus Pharmaceuticals breached Clause 9.2 over β€œsexual/titillating” Cetraben ad imagery (AUTH/2503/5/12)

A GP complained a Cetraben ad was offensive and degrading due to suggestive imagery. The Panel ruled the underwear-revealing image was attention-grabbing…

2012
CASE
AUTH/2483/2/12 Pfizer ⭐ Case of the Week

Pfizer breached ABPI Code over Prevenar 13 leavepiece implying a β€œnew indication” in HIV (AUTH/2483/2/12)

A Prevenar 13 leavepiece prominently linked HIV to a β€œNew Indication”, implying a licensed HIV indication and omitting key SPC cautions outside…

2008
CASE
Sandoz

Sandoz Omnitrope patient support items: water bottle and rucksack ruled in breach (Clause 18.2), soft toy allowed

Merck Serono challenged Sandoz’s Omnitrope β€œSproutz” items. PMCPA found the water bottle and rucksack were not directly related to growth hormone deficiency/patient…

2012
CASE
AUTH/2509/6/12 Roche Products

Anonymous v Roche (AUTH/2509/6/12): Late-night bar conduct at overseas congress led to high standards breach

At an overseas congress, Roche staff went to a late-night party bar where UK HCPs were present; one employee was escorted out.…

2012
CASE
AUTH/2563/11/12 Takeda

Takeda ruled in breach for perceived support of a luxury urology meeting (AUTH/2563/11/12)

Takeda UK was found in breach of Clause 9.1 after its Irish affiliate exhibited at an ISU meeting in Belfast held at…

2012
CASE
Shire Pharmaceuticals

Shire VPRIV press release: exploratory bone density data presented as confirmatory and comparative vs Cerezyme

Genzyme challenged a Shire VPRIV press release for implying head-to-head superiority on bone mineral density from exploratory endpoints. Appeal Board found multiple…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training